MPWT
HZNP

MassMutual Private Wealth & Trust’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-133
Closed -$15.4K – 2143
2023
Q3 		$15.4K Hold
133
– – ﹤0.01% 866
2023
Q2 		$13.7K Hold
133
– – ﹤0.01% 862
2023
Q1 		$14.5K Hold
133
– – ﹤0.01% 816
2022
Q4 		$15K Sell
133
-80
-38% -$6.64K ﹤0.01% 701
2022
Q3 		$13K Buy
213
+19
+10% +$1.33K ﹤0.01% 690
2022
Q2 		$9K Buy
194
+66
+52% +$6.25K ﹤0.01% 755
2022
Q1 		$13K Buy
128
+4
+3% +$390 ﹤0.01% 693
2021
Q4 		$13K Buy
+124
New +$13.5K ﹤0.01% 688

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MassMutual Private Wealth & Trust's HZNP Position: Q4 2023 in Review

MassMutual Private Wealth & Trust sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 133 shares — an estimated $15.4K sold.

MassMutual Private Wealth & Trust first reported a position in HZNP in Q4 2021 and held it in 8 quarters. The position peaked at $15.4K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • MassMutual Private Wealth & Trust reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 133 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $15.4K.
  • MassMutual Private Wealth & Trust first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 8 quarters.
  • MassMutual Private Wealth & Trust's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $15.4K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2023, filed 3 Jan 2024.